AB BioTechnologies Expands Services With Addition of Preclinical Manufacturing Capabilities


AB BioTechnologies, Inc. recently announced it is expanding its services to include preclinical manufacturing at its Bloomington, IN, facility.
New drug candidates must undergo preclinical studies to establish a toxicology profile and assess the safety, efficacy, and bioactivity prior to filing an Investigational New Drug (IND) application.

AB BioTechnologies has the capabilities and experience to perform the early stage development work (formulation, process, and analytical) through Good Laboratory Practice (GLP) manufacturing to support Preclinical/Toxicology studies. Whether the project is a large or small molecule, liquid or lyophilized, vial or syringe, AB BioTechnologies has the expertise to take a project from concept to clinic.

“AB BioTechnologies is excited to announce our newest service offering, GLP manufacturing. This is a natural progression for our company, given our existing pharmaceutical development capabilities. We are constantly looking for ways to make outsourcing easier for our clients and believe this expansion will help streamline the path to the clinic,” said J. Jeff Schwegman, PhD, Founder and CEO.

AB BioTechnologies will perform GLP manufacturing at their existing facility. Implementation of processes is underway, and they anticipate successful completion of a third-party audit by the end of Q3 2016.

AB BioTechnologies, Inc. is a contract service provider located in Bloomington, IN, providing pharmaceutical development services. AB BioTechnologies offers lyophilization cycle and process development services for injectable drugs, diagnostics, and tissue products. In conjunction with these services, AB BioTechnologies offers analytical and formulation development for large and small molecules, emulsions, suspensions, and oral solutions. The company was founded in February 2008 by Dr. J. Jeff Schwegman as a teaching and consulting firm. Since then, AB BioTechnologies has quickly grown, expanding services and laboratory space, to keep up with client demand. For more information, visit www.ab-biotech.com.